Hendrik Wessels
- Oncology top 10%
- Public Health, Environmental and Occupational Health top 5%
- Hematology top 5%
- Pathology and Forensic Medicine top 10%
- Immunology
- Co-authors
- Gerhard ZugmaierChristoph FaulVincent HaddadCarlos GrauxHervé DombretMassimiliano BonifacioAlbrecht ReichleDirk Nagorsen
- Topics
- Biosimilars and Bioanalytical Methods (7 papers)Neutropenia and Cancer Infections (6 papers)CAR-T cell therapy research (6 papers)
- Partner nations
- GermanySwitzerlandUnited Kingdom
In The Last Decade
Hendrik Wessels
13 papers receiving 626 citations
Hit Papers
Peers
Comparison fields: 5 of 43
- Oncology 401
- Public Health, Environmental and Occupational Health 387
- Hematology 275
- Pathology and Forensic Medicine 149
- Immunology 113
Countries citing papers authored by Hendrik Wessels
This map shows the geographic impact of Hendrik Wessels's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hendrik Wessels with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hendrik Wessels more than expected).
Fields of papers citing papers by Hendrik Wessels
This network shows the impact of papers produced by Hendrik Wessels. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hendrik Wessels. The network helps show where Hendrik Wessels may publish in the future.
Co-authorship network of co-authors of Hendrik Wessels
This figure shows the co-authorship network connecting the top 25 collaborators of Hendrik Wessels. A scholar is included among the top collaborators of Hendrik Wessels based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hendrik Wessels. Hendrik Wessels is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 21 | |
| 3 | 6 | |
| 4 | 1 | |
| 5 | 2 | |
| 6 | 1 | |
| 7 | 1 | |
| 8 | 4 | |
| 9 | 3 | |
| 10 | Blinatumomab for minimal residual disease in adults with B-cell precursor acute lymphoblastic leukemiabreakdown → | 516 |
| 11 | 4 | |
| 12 | 3 | |
| 13 | 39 | |
| 14 | 43 |
About Hendrik Wessels
Hendrik Wessels is a scholar working on Oncology, Immunology and Pharmacology, having authored 14 papers that have together received 644 indexed citations. Recurring topics across this work include Biosimilars and Bioanalytical Methods (7 papers), Neutropenia and Cancer Infections (6 papers) and CAR-T cell therapy research (6 papers). The work is most often cited by research in Hematology (275 citations), Oncology (401 citations) and Public Health, Environmental and Occupational Health (387 citations). Hendrik Wessels has collaborated with scholars based in Germany, Switzerland and United Kingdom. Frequent co-authors include Gerhard Zugmaier, Christoph Faul, Vincent Haddad, Carlos Graux, Hervé Dombret, Massimiliano Bonifacio, Albrecht Reichle, Dirk Nagorsen, Monika Brüggemann and Ralf C. Bargou. Their work appears in journals such as Blood, Neurology and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.